# D2 Pharma Consulting LLC — Form D

D2 Pharma Consulting LLC of CHESTERFIELD, MO, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-10. The offering totals $3.0M, of which $1.6M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2023-01-10
- Form: D
- Accession: 0001961414-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.6M
- Remaining: $1.4M
- Minimum investment: $100K
- Investors: 4
- Date of first sale: 2022-12-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-470120

## Issuer

- Name: D2 Pharma Consulting LLC
- CIK: 0001961414
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Address: 400 CHESTERFIELD CENTER, CHESTERFIELD, MO, 63017
- Phone: 636-537-7805

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Dean P Erhardt | Director | Chesterfield, MO |
| Steven P Kirchof | Director | Chesterfield, MO |
| Richard P Propper | Director | Chesterfield, MO |
| David P Suchanek | Director | Chesterfield, MO |
| John P Wagner | Director | Chesterfield, MO |
| Dean P Erhardt | Executive Officer | Chesterfield, MO |

## More

- [CIK 1961414 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1961414&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001961414-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.